Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-08

Clinical Trial Update: Confirmation of the Antiviral Effects of Midodrine Identified With a Gene Expression Signature-based Screening of Inluenza A Virus Infected Cells [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update confirming antiviral effects of midodrine identified through a gene expression signature-based screen in Influenza A virus-infecte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Midodrine (Midodrine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Influenza A Virus Infection | Phase 2 | Status: COMPLETED